The invention relates to an apparatus for creating linear lesions in body tissue within a body vessel.
Atrial fibrillation is an arrhythmic disorder where abnormal electrical signals are generated in the endocardial tissue causing irregular heart rhythm. Patients suffering from atrial fibrillation may, among other symptoms, have a feeling of skipped heart beats, chest discomfort, weakness and fatigue often resulting in reduced level of bodily function. Atrial fibrillation results in risk of systemic embolism and thereby stroke.
Interventional cardiologists have for many years used Radio Frequency Ablation in the treatment of atrial fibrillation. The treatment involves the attempt to isolate the pulmonary veins in the left atrium from the remaining electric conduction system of the heart. Such that the electrical signals generated in the endocardial tissue are blocked from affecting the heart rhythm.
Unfortunately the results of Radio Frequency Ablation have not been totally successful. The electric isolation often seems to be right after the procedure. However, the procedure results in an oedema of the tissue secondary to the ablation procedure and when the oedema disappears after a couple of weeks post-procedure the patient may experience new onset of atrial fibrillation. This is due to an incomplete isolation of the pulmonary veins in the left atrium from the remaining electric conduction system of the heart.
Devices for performing ablation of body tissue are known in the art, such as U.S. Pat. No. 6,190,382 which discloses a radio-frequency catheter system for ablating biological tissues of a body vessel in a patient including a catheter, a deployable antenna guide disposed at the distal portion of the catheter and a radio-frequency antenna mounted on the antenna guide. The radio-frequency antenna includes a helical coil which defines an axial passageway to accommodate the antenna guide, and is adapted to receive and transmit radio-frequency energy for tissue ablation. Upon deployment, the antenna guide acquires a loop configuration which establishes line contact with the body vessel conformable to its internal contour to prescribe the precise and affixed tissue ablation pathway despite body vessel movements. The radio-frequency antenna is carried by the antenna guide to be deployed along the established tissue ablation pathway.
Further, WO 97/32525 discloses an apparatus for ablating body tissue, and particularly for creating linear lesions within a chamber of a patient's heart, includes an elongate member having an ablation section. The ablation section includes an infusion tube and a plurality of spaced electrodes. The infusion tube and electrodes are covered by a fluid permeable foam material, and the foam material is covered by a fluid impermeable covering having a plurality of holes formed in it. During use, the ablation section is positioned against tissue to be ablated. Radiofrequency energy is delivered to the electrodes while saline or other conductive fluid is delivered to the infusion tube. The fluid exits the infusion tube at the ablation section, contacts the electrodes, and carries radio-frequency energy from the electrodes through the foam, through the holes in the covering and into contact with the body tissue to form a burn in the body tissue.
Among the problems of the prior art are the difficulty in controlling the ablation with high precision. In use the prior arts ablating conductor will change shape and position during the ablation process rendering it difficult to control depth and size of the lesions.
Considering the prior art described above, it is an object of the present invention to provide an apparatus for creating precise linear lesions in body tissue within a body vessel.
The object can be achieved by means of an apparatus for creating linear lesions in body tissue within a body vessel comprising, a catheter adapted for insertion into the body vessel, the catheter having a proximal end and a distal end, a loop of a non-conducting material at the distal end being deformable such that when the loop is pressed against a wall of the body vessel, a section of the loop conforms to the internal contours of the wall of the body vessel by changing the circumferential shape of the loop, a linear ablating conductor disposed on the loop, preferably along at least a part of the circumferential length of the loop, such that when the loop is pressed against the wall of the body vessel a portion of the linear ablating conductor is in contact with the body tissue in a smaller area than the total area of the section of the loop conformed to the internal contours of the wall of the body vessel.
Thus, it is possible to produce a linear lesion with high precision. When the loop of the present invention is pressed against the wall of the body vessel to be ablated it is not only the ablating conductor but also the non-conducting material of the loop that is in contact with the wall. This is because the portion of the ablating conductor in contact with the body tissue is smaller than the total area of the section of the loop conformed to the internal contours of the wall of the body vessel. Thus, the force applied to the wall is so to speak distributed to both the linear ablating conductor and the loop of a non-conducting material. Hence, the footprint of the linear ablating conductor is preferably smaller than the footprint of the loop, in particular the footprint of the part of the linear ablating conductor which comes in contact with the body vessel is preferably smaller than the footprint of the loop which comes in contact with the body vessel. The position and the deformation of the ablating conductor will then, to some extend, be controlled by the section of the loop conformed to the internal contours of the wall of the body vessel which is not covered by the ablating conductor.
Body vessel is to be understood as a cavity, duct or vessel within the body. When treating atrial fibrillation the body vessel is the cardiac lumen and the body tissue to be ablated is the myocardial wall. Hence, the terms “tissue wall” or “tissue wall of the body vessel” in this connection, may be used synonymously with the term myocardial wall.
It is to be understood that when the ablating conductor is in contact with the body tissue, it means that the ablating conductor is in thermodynamic contact so that the heat generated by the ablating conductor can ablate the body tissue. Conform can be understood as adapt; such that when the loop is pressed against a wall of the body vessel a section of the loop will adapt to the internal contours of the wall of the body vessel.
By the term “circumferential shape of the loop” as used herein, is meant the shape defined by the circumference of the loop.
The loop will typically substantially define a plane, i.e. the plane defined by the circumferential extension of the loop. By the term “orientation of the loop” as used herein, is meant the orientation, or the angle, of this plane.
By use of the present invention it is possible to create a linear ablation as the net sum of a plurality of linear lesions.
The linear ablating conductor can be supplied with current in order to heat it, this can for example be a high frequency alternating current, such as 350-500 kHz; this is known in the art as radio frequency ablation. The advantage of using high frequency alternating current compared to low frequency AC or pulses of DC is, that it does not directly stimulate nerves or heart muscle. The current can be delivered by use of conductors in the catheter.
It is important to have a good contact between the loop and the tissue wall, such that the energy transmission from the linear ablating conductor to the tissue wall can be controlled. Hence, it is advantageous that the circumferential shape of the loop is deformable such that it can conform to the internal contours of the wall of the body vessel. A tissue wall such as the myocardial wall may be a concave to varying degree.
In an embodiment of the invention, the circumferential shape of the loop is changed to a less convex shape, when the loop is pressed against a wall of the body vessel.
It is further important that the energy transmission from the linear ablating conductor is directed to the treated tissue, and that the dissemination of heat into the surrounding tissue and the local blood supply is reduced.
In an embodiment of the invention, the linear ablating conductor is disposed on the loop, and configured such that it covers a portion of the surface area of the loop that is smaller than the total surface area of the loop. This is exemplified in
A loop of a non-conducting material can be a thin strip of flexible material, for example a band of silicone, rubber or a plastic material. The use of non-conducting material ensures an insulation of the ablating conductor. The loop can be in the form of a band whereon the linear ablating conductor is arranged in the entire length of the loop.
Preferably, the width of the band is greater than the width of the linear ablating conductor.
In an embodiment, the catheter comprises a distal opening at the distal end and a lumen extending from the proximal end to the distal end wherein, the loop is adapted to be arranged within the lumen and deployable beyond the opening of the distal end. Thus, it is possible to unfold, or deploy, the loop and the ablating part of the apparatus when the catheter is in the correct position; this eases the insertion of the catheter.
For the treatment of atrial fibrillation using ablation, it may be necessary to create a linear ablation on the tissue, which is a net sum of a plurality of linear lesions, e.g. linear lesions in a pattern.
In an embodiment of the invention, the lumen comprises a guide which is connected to the loop such that the loop can be arranged within the lumen and deployed beyond the opening of the distal end, where the deployed orientation of the loop will be determined by the guide.
In a further embodiment, the deployed loop is partly or fully rotatable around a longitudinal axis defined by the length of the catheter, such that the orientation or angle of the loop can be changed.
In a further embodiment, the deployed loop is partly or fully rotatable around the longitudinal axis of the catheter, and wherein the rotation is obtained by a guide that can rotate within the catheter.
Advantageously, a plurality of ablating conductors disposed on the loop. Thus, it is possible to dissipate more energy to the body tissue.
In an embodiment, a plurality of impedance measuring conductors are disposed on the loop, such that when the guide loop is pressed against the wall of the body vessel the plurality of impedance measuring conductors make contact with the wall of the body vessel. By measuring the impedance between impedance measuring conductors, it is possible to ensure that the loop is in contact with the wall of the body vessel.
Preferably, the loop is in the form of a band whereon the plurality of impedance measuring conductor are arranged in the entire length of the loop and each impedance measuring conductor are insulated except in one point where the impedance measuring conductor is suitable for making contact with the wall of the body vessel. Points are to be understood as a small portion of the impedance measuring conductors, that are non-insulated such that a impedance measurement between two points can determine if the points are in contact with the body vessel and consequently if the linear ablating conductor is in contact with the body vessel. In this way it is possible to divide the loop and it can be tested if those segments have contact with the wall of the body vessel.
In an embodiment, the portion of the linear ablating conductor which is in contact with the body tissue has a length greater than 2 mm, more preferably 2.5 mm, and most preferably 5 mm or greater. Thus, it is possible to make a long linear ablation with only a few linear lesions.
Advantageously, the apparatus further comprises a tube at the distal end suitable for irrigation of the body tissue within the body vessel. Thus, it is, for example, possible to provide further cooling in order to prevent damages to surrounding tissue and/or body fluids.
In an embodiment, the area of the ablating conductor in contact with the body tissue is smaller than the area of the non-conducting material of the loop in contact with the body tissue. Hereby, control of the depth and size of the linear lesions is improved even further. Preferably, the area of the ablating conductor in contact with the body tissue is at least two times smaller than the area of the non-conducting material of the loop in contact with the body tissue.
In an embodiment the loop further comprises a temperature measuring conductor. This conductor can be used to determine the temperature of the wall of the body vessel. This can for example be done by measuring the change in conductivity of a temperature measuring conductor which is based on a change in temperature.
In an embodiment the loop further comprises an electrocardiographic (ECG) conductor, suitable for determining the electrical activity of the heart over time.
In an embodiment, the portion of the linear ablating conductor not in contact with the body tissue when the loop is pressed against the wall, is at least partly covered by an insulating material. Preferably, the portion of the linear ablating conductor is not in contact with the body tissue when the loop is pressed against the wall, and is covered in its entirety by an insulating material. Insulating the part of the ablating conductor that is not in contact with the body tissue minimizes the energy released to the surrounding tissue and/or bodily fluid. When treating atrial fibrillation the loop is positioned in the cardiac lumen which is filled with blood. When heating the blood there is a high risk of coagulation and consequently the production of an embolism which in some instances can lead to stroke. Therefore, it is highly desirable to minimize the energy released to surrounding fluids in order to minimize the side effects of ablating procedure. In addition, by limiting the energy released to the surrounding the energy loss is minimized resulting in an increased ablating capability of the ablating conductor in contact with the body tissue. Thus, the energy delivered to the conductor can be lowered if the same linear lesion is desired or a larger linear lesion can be created if the energy delivered to the conductor is kept at the same level.
The feature of, at least partly, insulating the portion of the ablating conductor that is not in contact with the body tissue to be ablated can advantageously be used for all apparatuses for creating lesions in body tissue within a body vessel. This can be defined in the following item:
An apparatus for creating lesions in body tissue within a body vessel comprising, a catheter adapted for insertion into the body vessel, the catheter having a proximal end and a distal end with a distal opening and a lumen extending from the proximal end to the distal end, an ablating conductor at the distal adapted to be pressed against a wall of the body vessel, such that a first portion of the ablating conductor is in contact with the body tissue and a second portion of the ablating conductor is not in contact with the body tissue wherein the second portion of the ablating conductor is at least partly covered by an insulating material. Preferably, the second portion of the ablating conductor is covered in its entirety by an insulating material.
An apparatus of the abovementioned type has the advantages as mentioned above. Further it is to be understood that it can be modified by any of the features presented in this document.
The invention also regards a method for ablating for creating linear lesions in body tissue within a body vessel, comprising the steps of, providing a catheter having a proximal end and a distal end with a loop of a non-conducting and deformable material at the distal end, manipulating the distal end of the catheter through the body and press the loop against a wall of the body vessel such that it conforms to the internal contours of the wall of the body vessel, supply energy to an ablating conductor disposed on the loop wherein the area of the ablating conductor in contact with the wall of the body vessel is smaller than the area of the loop in contact with the wall of the body vessel.
It is to be understood that in embodiments of the method it can be adapted to use any of the preferred embodiments of the apparatus mentioned in the present document.
The invention will in the following be described in greater detail with reference to the accompanying drawings:
In the following embodiments of the invention for treating atrial fibrillation is presented. Radio frequency energy is thus delivered to the ablating conductor in order to generate energy needed for ablating. The catheter is manoeuvred to the left atria where lesions in the myocardial wall (the wall of the body vessel) are created in order to isolate pulmonary veins in the left atrium from the remaining electric conduction system of the heart and thus blocking the excess electrical signals generated in the endocardial tissue from affecting the heart rhythm.
In
When the distal end 3 of the catheter 2 is adjacent to the myocardial wall 9 the loop 7 is deployed or unfolded, as shown in
When the loop 7 in the form of a band and with a ablating conductor 8 as shown in
In addition to the conductor disposed on the loop 7 shown in
The insulating layer 17 preferably also covers a small part of the ablating conductor 8 that conforms otherwise would be in contact with the myocardial wall 9 hereby it is ensured that the ablating conductor 8 does not get in contact with anything but the myocardial wall 9.
In order to make linear lesions 20 in the pattern 21 it is advantageously if the loop 7 can be rotated in relation to the catheter 2. This can for example be enabled by use of a guide 6 that can rotate within the catheter 2, which will enable the angling of the loop 7. During an ablating procedure where a pattern 21 as seen in
Items
Number | Date | Country | Kind |
---|---|---|---|
13195791.2 | Dec 2013 | EP | regional |
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/EP2014/076751 | 12/5/2014 | WO | 00 |